| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate |
1990-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_448d25c08ebb945fef448cc106d7fddb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0379e104a80aa39756574d0706e532c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_486ef5ebe7bf92b3adb5116d6ff2b8f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11264568b27cd5532902225d7f329dc6 |
| publicationDate |
1992-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DD-297555-A5 |
| titleOfInvention |
ANTIMYCOTIC GEL FORMULATIONS |
| abstract |
An antifungal gel formulation effective with 0.2 to 2 * of an antifungal imidazole and 0.01 to 2.5 * of an anti-inflammatory 17-ester esterified corticosteroid is contemplated for topical administration. This composition is highly effective in the treatment of fungal infections and can be stored for long periods of time without cooling, without sacrificing therapeutic efficacy, while maintaining uniformity and stability of the gel. |
| priorityDate |
1990-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |